About-cancer/treatment/drugs/everolimus/zh
依維莫司
該頁面包含有關依維莫司的簡要信息，以及一些連結的集合，這些連結指向有關該藥物的使用，研究結果和正在進行的臨床試驗的更多信息。
美國品牌名稱
Afinitor
Afinitor Disperz
Zortress
FDA批准
是
該藥物的FDA標籤信息可從DailyMed獲得。
用於癌症
依維莫司被批准用於治療：
- 乳腺癌. 它與依西美坦聯合用於絕經後患有晚期激素受體陽性（HR +）乳腺癌且HER2陰性（HER2-）的女性，經來曲唑或阿那曲唑治療後並未好轉。
- 胰腺癌, 胃腸道癌和肺癌（某些類型）。 它用於患有無法通過手術切除，局部晚期或轉移（擴散到身體其他部位）的進行性神經內分泌腫瘤的成年人。
- 腎細胞癌（一種腎癌）晚期患者，在接受舒尼替尼或索拉非尼治療後病情並未好轉的成年人中。
- 室管膜下巨細胞星形細胞瘤 在患有結節性硬化症且無法進行手術的成人和1歲或1歲以上的兒童中。
Afinitor和Afinitor Disperz品牌已批准使用依維莫司治療癌症。 依維莫司也被批准用於治療移植排斥反應。 此用途已獲Zortress品牌認可。
依維莫司也正在治療其他類型的癌症。
關於依維莫司的更多信息
NCI藥物詞典中的定義-該藥物的詳細科學定義和其他名稱。
MedlinePlus Information on Everolimus - A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
Research Results and Related Resources
Targeted Cancer Therapies
Combination Therapy Shows Promise for Treating Advanced Breast Cancer
Targeted Therapies May Be Effective Against Rare Pancreatic Cancer
Clinical Trials Accepting Patients
Find Clinical Trials for Everolimus - Check for trials from NCI's list of cancer clinical trials now accepting patients.
Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
